First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.82 EUR 0.71% Market Closed
Updated: May 3, 2024

BRAIN Biotech AG
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Gross Profit Peer Comparison

Comparables:
WCH
EVK
1COV
ACT
SY1

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Gross Profit
€31m
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Gross Profit
€1.1B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
5%
Evonik Industries AG
XETRA:EVK
Gross Profit
€4.1B
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
1%
Covestro AG
XETRA:1COV
Gross Profit
€2.3B
CAGR 3-Years
-3%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Gross Profit
€308.1m
CAGR 3-Years
8%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Gross Profit
€1.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
9%

See Also

What is BRAIN Biotech AG's Gross Profit?
Gross Profit
31m EUR

Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Gross Profit amounts to 31m EUR.

What is BRAIN Biotech AG's Gross Profit growth rate?
Gross Profit CAGR 5Y
6%

Over the last year, the Gross Profit growth was 5%. The average annual Gross Profit growth rates for BRAIN Biotech AG have been 15% over the past three years , 6% over the past five years .